Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.
GHTC sent a letter to members of the Senate Armed Services Committee and members of the Senate Appropriations Subcommittee on Defense urging them to oppose provisions in the fiscal year 2017 National Defense Authorization Act that would threaten medical research at the US Department of Defense.
Intellectual Property Watch highlights remarks made at a GHTC event and webinar on global health R&D issues on the World Health Assembly (WHA) agenda.
We share our lessons learned in building a diverse, effective advocacy coalition for global health R&D.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.